176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.81%
Negative revenue growth while Technology median is -0.87%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-0.55%
Negative gross profit growth while Technology median is 0.00%. Seth Klarman would suspect poor product pricing or inefficient production.
-1.41%
Negative EBIT growth while Technology median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-1.41%
Negative operating income growth while Technology median is -2.69%. Seth Klarman would check if structural or cyclical issues are at play.
-3.47%
Negative net income growth while Technology median is -2.86%. Seth Klarman would investigate factors dragging net income down.
-5.13%
Negative EPS growth while Technology median is -0.62%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-2.63%
Negative diluted EPS growth while Technology median is -0.93%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
0.33%
Share growth above Technology median by more than 2x. Jim Chanos would suspect over-dilution or repeated equity raises.
0.16%
Diluted share change of 0.16% while Technology median is zero. Walter Schloss might see a slight difference in equity issuance policy.
-0.33%
Dividend cuts while Technology median is 0.00%. Seth Klarman would see if others maintain or grow payouts, highlighting a relative weakness.
-37.95%
Negative OCF growth while Technology median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-42.92%
Negative FCF growth while Technology median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
184.00%
10Y revenue/share CAGR exceeding 1.5x Technology median of 29.79%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
139.27%
5Y revenue/share growth exceeding 1.5x Technology median of 22.96%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
53.31%
3Y revenue/share growth exceeding 1.5x Technology median of 11.44%. Joel Greenblatt might see a short-term competitive advantage at play.
15658.45%
OCF/share CAGR of 15658.45% while Technology median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
230.39%
OCF/share CAGR of 230.39% while Technology median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
210.79%
3Y OCF/share growth of 210.79% while Technology median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
515.64%
Net income/share CAGR exceeding 1.5x Technology median of 46.52% over a decade. Joel Greenblatt might see a standout compounder of earnings.
511.88%
5Y net income/share CAGR > 1.5x Technology median of 55.21%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
74.39%
3Y net income/share CAGR > 1.5x Technology median of 23.79%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
322.99%
Equity/share CAGR exceeding 1.5x Technology median of 43.02% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
157.07%
5Y equity/share CAGR > 1.5x Technology median of 34.31%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
105.96%
3Y equity/share CAGR > 1.5x Technology median of 18.35%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
90.49%
5Y dividend/share CAGR of 90.49% while Technology is zero. Walter Schloss sees at least some improvement that could compound over time.
15.23%
3Y dividend/share CAGR of 15.23% while Technology is zero. Walter Schloss sees a slight advantage if the firm is at least inching up payouts.
15.09%
AR growth of 15.09% while Technology median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
15.22%
Inventory growth of 15.22% while Technology median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
34.30%
Asset growth exceeding 1.5x Technology median of 0.64%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
6.98%
BV/share growth exceeding 1.5x Technology median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
196.94%
Slightly rising debt while Technology median is deleveraging. Peter Lynch wonders if the firm lags behind peers in risk control or invests in more expansions.
-0.41%
R&D dropping while Technology median is rising. Seth Klarman wonders if we risk ceding future innovation or if peers overspend.
2.09%
SG&A growth of 2.09% while Technology median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.